chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came in the Tuesday following the immunization and complained of swelling, sorness, and redness at and around the injection site. She showed me the site and it was still visibly swollen and there was some redness a few inches below the injection site. She had been to the gym and done some lifting, so that may have contributed to the swelling somewhat.
Breakthrough case admission after three vaccines 2/26/21 Pfizer Lot# EN6200;  3/19/21 Pfizer  Lot# ER8727;  12/21/21 Moderna Lot# 032H21A
After the last Rabies vaccine given on 2/18/19 the following day 2/19/19 patient started a fever. He was taken right to the doctors where he was looked over, checked for the flu (negative) and ear infections (negative).  By 9:00pm that evening his fever was 104.7. He also seemed sensitive to touch and uncomfortable. Being in contact with nurse. Patient received tylenol and motrin as advised to break fever and room temperature bath. The highest his fever reached was 105.3. Doctors advised continuing tylenol, motrin and keeping up on fluids and if child was not better by the end of the week to have him seen again, they suggested that this was a virus that just needed to run its course. Fevers stopped by Sunday 2/24/19.
Fever, chills, heart palpitations for 3 days, arm limited movement for 2 days, arm red, swollen, warm, itchy still ongoing but to a lesser degree than several days ago.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On 30-SEP-2016, the patient was inadvertently vaccinated with improperly stored dose of GARDASIL (lot # M014929, expiration date 27-MAY-2017, dose and route of administration were not reported). The administered dose experienced a temperature excursion for 15 hours. No previous temperature excursion was reported. No adverse effects were reported. No product quality complaint (PQC) was filed. Additional information has been requested.
seizure for about 10-15 seconds; Initial information received on 12-Aug-2020 regarding an unsolicited valid serious case received from a pharmacist.  This case involves an unknown demographic patient who experienced seizure, while received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past vaccination included FLUZONE QUADRIVALENT but she was not allergic to it. The patient's other medical history, past medical treatment, family history and concomitant medication were not provided.  On 12-Aug-2020, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number and expiry date were not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On 12-Aug-2020, the patient developed a serious seizure one minute (also reported as within 30 seconds) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This event was assessed as medically significant.  Details of laboratory data was not reported.  Final diagnosis was seizure.  It was not reported if the patient received any corrective treatment.  On 12-Aug-2020, the patient had recovered from the event (reported as lasted for 10-15 seconds).  Information on batch number is requested.; Sender's Comments: This case concerns an unknown demographic patient who experienced seizure one minute following the vaccination with FLUZONE QUADRIVALENT. The time to onset is compatible for the role of vaccine. However, the patient's medical history, medical condition at the time of vaccination and laboratory data ruling out other etiologies were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Pale, blue around eyes, muscles/hands contracted, unable to move hands or feet.  O2 - 100%, BP 110/74, Pulse 112.   Called for ambulance.  By the time the ambulance arrived her hands and feet improved and she was able to move extremities.  She was able to sit up.
Chills, sweats (fever), nausea, vomiting within 6-8 hrs after vaccine. Lasted 5-6 days then mild within 1 1/2 wks. Fingers contracted. Joints started to ache six months later with crackling of neck and spine and knee joints for 3 months still present.
This spontaneous report was received from a register nurse refers to an unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. The register nurse informed that from 21-NOV-2014 through 16-JAN-2015 the patients were vaccinated with doses of GARDASIL 0.5 ml, intramuscular, (lot# and expiration date were not reported) that were improperly stored. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Abnormal menstrual, 2 Straight months, light flow, and spotting still to date.
Hives on torso, arms, and legs; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 10Apr2021 at 09:30(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos disease and high cholesterol. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 20Mar2021 at 09:45 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 09:30 the patient experienced hives on torso, arms, and legs. On 13Apr2021, the patient underwent (COVID 19 virus test) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of hives on torso, arms, and legs and included treatment with Benadryl (MANUFACTURER UNKNOWN) on her own on an unknown date.  The clinical outcome of the event hives on torso, arms, and legs was resolved on an unknown date.   No follow-up attempts are needed. No further information is expected.
I was awakened at 3:00 AM on 12/5 with extreme pain in my left arm.  I took 2 Advils.  Upon awakening at 9:00 AM, my are hurt worse and the tired and achy feeling set in.  I have no chills, fever nor sore throat.
Swelling (Edema, Edema)(Edema) - recovered/resolved Redness (Rash, rash)(Rash) - recovered/resolved Warmth (Vasodilatation, vasodilatation)( Vasodilat) - recovered/resolved Pain (Pain, pain)(Pain) - recovered/resolved A report was received from an office manager on 11 November 2003 concerning a female vaccinee in her 20's who experienced swelling, redness, warmth and pain on the same day as receiving Fluvirin on 10 November 2003. On 10 November 2003 the vaccinee experienced swelling, redness, warmth and pain. The pain had been becoming milder at the time of the report. The vaccinee had not recovered at the time of the report. Update 1, 25 November 2003: Further information was received from an office manager on 25 November 2003 indicating that the swelling, redness, warmth and pain experienced by the 23 year old female vaccinee resolved 2 days after onset, on 12 November 2003. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
headache, diffuse/migratory paresthesias, 'brain fog', palpitations, dizziness
Thursday am in school patient reported itching, progressed to a blotchy, wet-like rash on lower extremities on thurs afternoon and evening. On Fri 2 waits noted on abd. That is when grandmother called Health dept.
ACHE; BODY TIGHTNESS; This spontaneous report received from a patient concerned a 37 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included kidney stones, non smoker, and non alcohol user, and other pre-existing medical conditions included the patient had no known drug allergies. the patient have socially drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) 0.5 ml, administered on 09-APR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced body tightness. On 10-APR-2021, the subject experienced ache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from ache on 16-APR-2021, and body tightness on 12-APR-2021. This report was non-serious. This case, from the same reporter is linked to 20210436462.
6 syringes were drawn up @ 9:07 AM on 8/3/21 and marked with an expiration sticker with the time of 3:07pm.  Vaccine was inadvertently given @ 4:12 pm.   Patient was contacted and informed and reports no side effects.  Advised that we would contact Pfizer to find out the next steps and to see if he will need to start the series over again..  Will  contact patient once we hear back from Pfizer about validity of vaccine.
7-16-09 pm noticed swelling adn redness at inj. site.  In clinic 7-17-09 upper arm red with hard knot and swelling of right arm at inj. site.Area of 2 1/2 by 3cm induration with 5cm of redness at MMR site.
Pt recv vax on 4/21/99; on 4/25/99 pt exp chicken pox; on 5/3/99 pt exp a different rash w/ difficulty breathing, eyelids & nose turned purple; dx=allergic rxn; tx=Prelone syrup
This spontaneous report received from a registered nurse refers to a patient of unknown age and gender. Information on pertinent medical history and concurrent condition was not provided. On an unknown date, the patient was vaccinated with improperly stored VARIVAX (Incorrect product storage) from lot # M038856 expiry date 14-SEP-2018 for prophylaxis. Lot M038856 was stored in the range of -14°C to-10°C for 483 hours and in the range of -9°C to 8°C for 28 hours. No previous temperature excursion was reported. The call was not because of a "data logger".  The reporter was unable to provide the lot number and expiration date for the properly stored sterile diluent that were used to reconstitute the vaccines. No adverse effects reported. No PQC has been filed. No additional information is available. This is one of the several reports reported from same source. Additional information has been requested.; Sender's Comments: US-009507513-1707USA010912: US-009507513-1707USA010913: US-009507513-1707USA010914: US-009507513-1707USA010915: US-009507513-1707USA010916: US-009507513-1707USA010917: US-009507513-1707USA010918: US-009507513-1707USA010919: US-009507513-1707USA010920: US-009507513-1707USA010921: US-009507513-1707USA010922: US-009507513-1707USA010923: US-009507513-1707USA010927: US-009507513-1707USA010910:
perspired profusely all noc following the flu shot; woke up next morning w/a sore thraot & laryngitis; sx lasted 48 hrs;
Moderate to severe pain over the weekend (7/7-8), popping sensation in shoulder and joint pain. Currently will be OK during the day, then will feel popping and onset of pain in the afternoon and evening, through late morning.
Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster; Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster; This spontaneous case was reported by a consumer and describes the occurrence of SECRETION DISCHARGE (Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster) and CONDITION AGGRAVATED (Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 028L20A and 11J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Arthritis and Blood pressure. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SECRETION DISCHARGE (Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster) and CONDITION AGGRAVATED (Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster). The patient was treated with AMOXICILLIN for Adverse event, at an unspecified dose and frequency and CORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, SECRETION DISCHARGE (Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster) and CONDITION AGGRAVATED (Thick mucus draining on the back of their throat/it was terrible/never truly went away/Fleur up again after the booster) had not resolved.            Patient was treated  common allergy medication  and took dose pack cortisone .   This case was linked to MOD-2021-388573 (Patient Link).
Starting the next day after the vaccine (03/31/2021), I started getting itchy but wasn't to concerned at that time. Over the next couple of days, I was scratching but about the 3rd day after the vaccine I had a "raging" yeast infection and hives all over my body including the genital area. I took an OTC yeast infection medicine, but it did not treat the yeast infection. So, I started taking Fexofenadine, but that did not resolve the hives. I called my PCP and saw one of her associates a few days later. She gave me a steroid cream mixed with a yeast cream for my genital area. Also, I got an antifungal pill that I took orally for a week, which alleviated the genital hives and yeast infection. I was told to take Benadryl for the other hives, and I was not given steroid cream for them. The Benadryl didn't work well and I ended up scratching the skin off the sores. She advised me to double up the dosage of the Benadryl before the 2nd shot. When I went, they refused to give me the second shot due to me having an allergic reaction. So, I was advised to go to an allergist and get a note stating that I was cleared for the shot. I made an appointment with (allergist) but it wasn't until several weeks later. She stated that she was unsure if the hives were caused by the vaccine or not, but thought it would be better to be protected against COVID-19. She said that I would need to trial out allergy medicines to deal with the hives. Told me to take double the normal amount of Claritin, and can take up to 4 a day if I needed too. Also, she ordered blood tests to check my antibody level for the vaccine. She said if she felt the antibody level test was high enough then she would advise against another dose. So, I got the test done, and I picked up the Claritin which "worked like a charm". It resolved the itchiness and the blood test showed I have some antibodies and she told me to not get another shot until the booster comes out. She told me to consider myself fully vaccinated. I tried to stop the Claritin thinking I didn't have the hives anymore, but they came back after cutting back 2 pills. So, I still have whatever is going on.
Headache. Tingling in hands. Weak. Nausea. Hip/back pain.
I received Three COVID- 19  Moderna Jabs    the first on March 26 and second April 23    The Adverse Events took place between the date of the first vaccine and through the second and third vaccines  I did not make the connection until reading several news reports on side effects -  heart palpatations and flutters  I had a battery of cardio tests completed since
Patient reported tingling sensation at inj site, stiff neck, scalp irritation...Pt had not sought medical attention as of 11/12/13. Condition was improving. Symptoms began 3 days after receiving vaccine.
Swelling the size of an egg; Hard at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling the size of an egg) and VACCINATION SITE INDURATION (Hard at injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling the size of an egg) and VACCINATION SITE INDURATION (Hard at injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling the size of an egg) and VACCINATION SITE INDURATION (Hard at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Immediate injection sight reaction of redness and swelling; Immediate injection sight reaction of redness and swelling; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (Immediate injection sight reaction of redness and swelling) and VACCINATION SITE SWELLING (Immediate injection sight reaction of redness and swelling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Immediate injection sight reaction of redness and swelling) and VACCINATION SITE SWELLING (Immediate injection sight reaction of redness and swelling). At the time of the report, VACCINATION SITE ERYTHEMA (Immediate injection sight reaction of redness and swelling) and VACCINATION SITE SWELLING (Immediate injection sight reaction of redness and swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported by the reporter. Treatment details was not reported by the reporter.
A few hours after receiving my second dose, I fainted while walking down the stairs in my house.  I lost feeling in my body from my neck down as I was taking a step down a stair. I then felt intense pain in my feet as I fainted and fell to the bottom of the stairs. I landed flat on my face at the bottom. I immediately went to the ER where X-rays showed I displaced my fifth metatarsal in my right foot.
1400 administered 2nd inject in Hepatitis series w/Engerix-B; 1445 color flushed c/o not feeling well-assist to supine position; 1530 color became pale & skin cool & clammy; c/o dizziness extreme thirst;
BODY ACHES; CHILLS; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a health care professional. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068 expiry: 25-MAY-2021) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced body aches. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced fever. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, fever, headache, and nausea on 28-MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210429909.
FLU LIKE SYMPTOMS; STOMACH DISCOMFORT; BODY ACHES; CHILLS; FEVER; NAUSEA; HEADACHE; TIRED; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980,expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced flu like symptoms. On 08-APR-2021, the subject experienced stomach discomfort. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced tired. On 13-APR-2021, treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, nausea, flu like symptoms, headache, chills, stomach discomfort, and body aches, and the outcome of tired was not reported. This report was non-serious.
One hour post vax pt had difficulty breathing. Pt was treated in ER with oxygen. Pt was 3.5 years old at the time of the episode.
A spontaneous report was received from a 65 year old female consumer who on 27-AUG-2014 received ZOSTAVAX in her upper arm (lot # not reported). Concomitant medications included tramadol, amlodipine besylate, alprazolam, carisoprodol and omeprazole. She is allergic to sulfa. She stated she had no pertinent medical history. in the first week of November 2014, she developed rash like bumps. She explained that she has a curvature in her back and she strained her back doing gardening in September 2014. Since then, she was always able to use ice or heating pads on her back to ease the pain. But in the first week of November 2014, whenever she used the ice packs she would get a strong burning sensation. She would have to stop using them immediately. This has been going on for about two weeks now. The female described the rash and "little pimple-like bumps" on her back from the spine going up her side. It is about five or six inches long in length. She stated her chiropractor stated that it looked like a rash on her back. She did not seek medical attention for the events. The outcome of the events were unknown. Additional information has been requested.
Patient received the Covid 19 vaccine on 12/24/2020. On 12/26/2020 she c/o new onset fatigue, bodyache, cough, headache, sore throat.  The dry cough and sore throat are worsening. Denies fever or chills.  Covid test scheduled on 12/28/2020 at Employee Health.
fever 102 degree max, lethargy/confined to bed for 48-hours, fatigue for 72 hours